Press release

Masimo Reports Third Quarter 2022 Financial Results

Third Quarter 2022 Highlights Consolidated revenue was $549 million; Healthcare revenue was $327 million, representing 6% reported growth and 10% constant

articleMasimo CorporationNovember 8, 20223/company/masimo-corporation/news/masimo-reports-third-quarter-2022-financial-results-2022-11-08
Masimo Reports Third Quarter 2022 Financial Results

About this update from Masimo Corporation

[{"type":"text","content":"\nThird Quarter 2022 Highlights\n\n\nConsolidated revenue was $549 million;\n\n\nHealthcare revenue was $327 million, representing 6% reported growth and 10% constant currency growth; and\n\n\nNon-healthcare revenue was $222 million.\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo (Nasdaq: MASI) today announced its financial results for the third quarter of 2022, ended October 1, 2022.\n\nThird Quarter 2022 Financial Results\n\nConsolidated revenue was $549.3 million, representing 78.7% reported growth compared to $307.4 million in the third quarter of 2021. Healthcare revenue was $327.2 million, which represents 6.4% reported growth and 10.0% growth on a constant currency basis. Non-healthcare revenue was $222.1 million.\n\nExcluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 76,100.\n\nFor the third quarter of 2022, on a consolidated basis, GAAP net income was $37.9 million, or $0.70 per diluted share, which includes expenses related to the Sound United acquisition. Non-GAAP net income was $53.9 million, or $1.00 per diluted share, for the quarter.\n\nJoe Kiani, Chairman and Chief Executive Officer of Masimo, said “We delivered strong results in the third quarter with revenue and earnings exceeding expectations. Our healthcare segment achieved double digit constant currency growth and our consumer non-healthcare segment reported another quarter of better-than-expected results. Our performance in the third quarter was achieved in a challenging environment and made possible by commendable contributions from our entire team.”\n\nFor additional financial details, please visit the Investor Relations section of the Company’s website at investor.masimo.com to access the third quarter 2022 Earnings Presentation materials.\n\nFourth Quarter 2022 and Full Year 2022 Financial Guidance\n\nThe Company provided the following estimates for its fourth quarter and full year 2022 guidance:\n\n\n\n \n\n\n\n \n\n\n\nFourth Quarter\n\n\n2022 Guidance(1)\n\n\n\n \n\n\n\nUpdated Full Year\n\n\n2022 Guidance(1)\n\n\n\n\n\n(in millions, except earnings per diluted share)\n\n\n\n \n\n\n\nGAAP\n\n\n\n \n\n\n\nNon-GAAP\n\n\n\n \n\n\n\nGAAP\n\n\n\n \n\n\n\nNon-GAAP\n\n\n\n\n\nConsolidated revenue\n\n\n\n \n\n\n\n$581 to $611\n\n\n\n \n\n\n\n$581 to $611\n\n\n\n \n\n\n\n$2,000 to $2,030\n\n\n\n \...

More updates from Masimo Corporation